A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 245,102 shares of ANIP stock, worth $13.8 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
245,102
Previous 156,802 56.31%
Holding current value
$13.8 Million
Previous $9.99 Million 46.44%
% of portfolio
0.02%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$54.33 - $65.72 $4.8 Million - $5.8 Million
88,300 Added 56.31%
245,102 $14.6 Million
Q2 2024

Aug 09, 2024

BUY
$58.53 - $68.82 $1.22 Million - $1.44 Million
20,900 Added 15.38%
156,802 $9.99 Million
Q1 2024

May 13, 2024

BUY
$54.2 - $69.69 $2.18 Million - $2.81 Million
40,303 Added 42.16%
135,902 $9.4 Million
Q4 2023

Feb 13, 2024

BUY
$48.72 - $65.43 $2.73 Million - $3.66 Million
55,997 Added 141.4%
95,599 $5.27 Million
Q3 2023

Nov 14, 2023

SELL
$50.28 - $64.61 $1.09 Million - $1.4 Million
-21,700 Reduced 35.4%
39,602 $2.3 Million
Q2 2023

Aug 11, 2023

BUY
$37.29 - $53.83 $2.29 Million - $3.3 Million
61,302 New
61,302 $3.3 Million
Q2 2022

Aug 12, 2022

SELL
$23.09 - $33.46 $2.05 Million - $2.96 Million
-88,602 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$26.91 - $47.15 $266,409 - $466,785
-9,900 Reduced 10.05%
88,602 $2.49 Million
Q4 2021

Feb 11, 2022

BUY
$32.97 - $56.85 $1.33 Million - $2.29 Million
40,202 Added 68.96%
98,502 $4.54 Million
Q3 2021

Nov 12, 2021

SELL
$26.48 - $35.99 $240,411 - $326,753
-9,079 Reduced 13.47%
58,300 $1.91 Million
Q2 2021

Aug 13, 2021

SELL
$31.86 - $38.6 $1.52 Million - $1.85 Million
-47,823 Reduced 41.51%
67,379 $2.36 Million
Q1 2021

May 13, 2021

SELL
$28.4 - $36.14 $1.18 Million - $1.5 Million
-41,502 Reduced 26.48%
115,202 $4.16 Million
Q4 2020

Feb 10, 2021

BUY
$23.69 - $31.47 $324,600 - $431,201
13,702 Added 9.58%
156,704 $4.55 Million
Q3 2020

Nov 13, 2020

SELL
$26.38 - $33.1 $801,899 - $1.01 Million
-30,398 Reduced 17.53%
143,002 $4.03 Million
Q2 2020

Aug 13, 2020

SELL
$29.93 - $50.1 $2.66 Million - $4.45 Million
-88,900 Reduced 33.89%
173,400 $5.61 Million
Q1 2020

May 14, 2020

SELL
$30.35 - $67.14 $109,260 - $241,704
-3,600 Reduced 1.35%
262,300 $10.7 Million
Q4 2019

Feb 13, 2020

SELL
$55.65 - $79.83 $3.75 Million - $5.37 Million
-67,300 Reduced 20.2%
265,900 $16.4 Million
Q3 2019

Nov 13, 2019

BUY
$64.7 - $85.39 $2.92 Million - $3.85 Million
45,100 Added 15.65%
333,200 $24.3 Million
Q2 2019

Aug 12, 2019

BUY
$67.77 - $82.2 $6.02 Million - $7.31 Million
88,900 Added 44.63%
288,100 $23.7 Million
Q1 2019

May 14, 2019

BUY
$45.83 - $70.54 $1.37 Million - $2.1 Million
29,800 Added 17.59%
199,200 $14.1 Million
Q4 2018

Feb 13, 2019

BUY
$41.17 - $56.44 $6.97 Million - $9.56 Million
169,400 New
169,400 $7.63 Million

Others Institutions Holding ANIP

About ANI PHARMACEUTICALS INC


  • Ticker ANIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 17,426,000
  • Market Cap $982M
  • Description
  • ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...
More about ANIP
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.